| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |